Life Sciences Investor Survey IV | Report | FTI Consulting

Life Sciences Investor Survey IV

Expectations for the Sector in 2014

Strategic Communications

February 27, 2014

a dna design

FTI Consulting — Strategic Communications’ fourth annual Life Sciences Investor Survey assesses European and U.S. investors’ insights and expectations around a number of key industry-related topics.

The study’s findings underscore investors’ overall optimism toward the outlook for healthcare stock performance and the anticipated continued strength of the transaction environment in the sector. The research also reveals a number of key trends in shareholder engagement for healthcare and life sciences companies to consider.

Webinar

A panel of healthcare and finance experts discusses the results from FTI Consulting’s fourth annual Life Sciences Investor Survey, and explores the market dynamics currently driving investment decisions and transactions in the industry.

Featured speakers include:

  • Judy Brown, Executive Vice President and Chief Financial Officer, Perrigo Company
  • Tom Crawford, Senior Managing Director, FTI Consulting — Strategic Communications
  • Alan Hartman, Partner, Centerview Partners
  • Barbara Ryan, Managing Director, FTI Consulting — Strategic Communications

This webinar is complimentary, aimed at corporate advisers and executives in the healthcare and life sciences sector.

Research Methodology

FTI Consulting – Strategic Communications executed primary research among 83 healthcare-focused, buy-side investors from Europe and the U.S. in December 2013, so as to provide a diverse and global perspective on the current state of the healthcare industry.


More Info

Share this page